In contrast, lymphomas with dual MYC and BCL6 rearrangements represent a more diverse group and have variable gene expression profiles and mutational spectra, making them markedly different from DLBCL/HGBL-MYC/BCL2 [21]. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.